Potential new treatment for COVID-19 uncovered by BenevolentAI enters trials

BenevolentAI, a startup which has raised $292 million to apply AI to create drugs faster, today says it has uncovered an already approved drug as a potential treatment for COVID-19, after it applied i

BenevolentAI starts AI collaboration with AstraZeneca to accelerate drug discovery

BenevolentAI is an AI company where AI actually means something. Founded in 2013, it focuses on “accelerating the journey from data to medicines.” To achieve that, it has raised a whopping

BenevolentAI, which uses AI to develop drugs and energy solutions, nabs $115M at $2B valuation

In the ongoing race to build the best and smartest applications that tap into the advances of artificial intelligence, a startup out of London has raised a large round of funding to double down on sol

Advances in AI and ML are reshaping healthcare

The application of AI/ML in healthcare is reshaping the industry and making what was once impossible into a tangible reality.

BenevolentBio’s artificial intelligence could discover a better treatment for ALS

What if the drug that could effectively treat amyotrophic lateral sclerosis, the paralyzing neurological disease that skyrocketed into the public consciousness thanks to the ice bucket challenge, alre

Bioscience meets AI — Dr. Jackie Hunter of BenevolentAI to speak at Disrupt London

Disrupt hits London December 5-6 and it is our pleasure to announce that Dr. Jackie Hunter, Board Director of BenevolentAI and CEO of BenevolentBio, will be joining us as one of our featured speakers